Inventor · disambiguated record
Annika Nelde
Also filed as: NELDE ANNIKA
10 granted patents·13 pending applications·2 citations·filing 2018–2025
83Inventor score
Files withIMMATICS BIOTECHNOLOGIES GMBH18UNIV TUEBINGEN MEDIZINISCHE FAKULTAET4UNIV EBERHARD KARLS TUEBINGEN1
Top patents by PatentIndex Score
23 records- 0190US11542303B2Peptides and combination thereof for use in the immunotherapy against cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Granted Jan 3, 2023·1 cites·9 claims
- 0283US11135246B2Peptides and combination of peptides for use in immunotherapy against leukemias and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted Oct 5, 2021·1 cites·22 claims
- 0379US11560405B2Peptides and combination thereof for use in the immunotherapy against cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2022·Granted Jan 24, 2023·0 cites·20 claims
- 0475US11559550B2Peptides and combination of peptides for use in immunotherapy against leukemias and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2022·Granted Jan 24, 2023·0 cites·20 claims
- 0575US2023346837A1Peptides and combination thereof for use in the immunotherapy against cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2023·Application pending·0 cites
- 0674US11103534B2Peptides and combination thereof for use in the immunotherapy against cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted Aug 31, 2021·0 cites·20 claims
- 0774US2021213065A1Peptides and combination thereof for use in the immunotherapy against cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Application pending·0 cites
- 0874US2022332760A1Peptides and combination thereof for use in the immunotherapy against cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2022·Application pending·0 cites
- 0973US11427614B2Peptides and combination thereof for use in the immunotherapy against cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2018·Granted Aug 30, 2022·0 cites·16 claims
- 1072US11020432B2Peptides and combination thereof for use in the immunotherapy against cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted Jun 1, 2021·0 cites·20 claims
- 1172US11007223B2Peptides and combination thereof for use in the immunotherapy against cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted May 18, 2021·0 cites·20 claims
- 1272US2020339656A1Peptides and combination thereof for use in the immunotherapy against cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Application pending·0 cites
- 1371US10899819B2Peptides and combination of peptides for use in immunotherapy against leukemias and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2018·Granted Jan 26, 2021·0 cites·16 claims
- 1471US2021161962A1Peptides and combination of peptides for use in immunotherapy against leukemias and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Application pending·0 cites
- 1571US2020190160A1Peptides and combination thereof for use in the immunotherapy against cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Application pending·0 cites
- 1670US10993963B2Peptides and combination of peptides for use in immunotherapy against leukemias and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted May 4, 2021·0 cites·20 claims
- 1768US2022118016A1Peptides and combination of peptides for use in immunotherapy against leukemias and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Application pending·0 cites
- 1868US2020207831A1Peptides and combination of peptides for use in immunotherapy against leukemias and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Application pending·0 cites
- 1965US2025339503A1Peptides and combinations of peptides for use in immunotherapy against acute myeloid leukemia (aml) and other hematological neoplasmsUNIV TUEBINGEN MEDIZINISCHE FAKULTAET·Filed 2025·Application pending·0 cites
- 2063US2023322865A1Peptides and Combinations of Peptides for Use in Immunotherapy Against an Infection by Sars-COV-2 (COVID-19)UNIV TUEBINGEN MEDIZINISCHE FAKULTAET·Filed 2023·Application pending·0 cites
- 2162US2023279073A1Peptides and combinations of peptides for use in immunotherapy against hematologic neoplasms and other cancersUNIV TUEBINGEN MEDIZINISCHE FAKULTAET·Filed 2022·Application pending·0 cites
- 2262US2023405108A1Peptides and combinations of peptides for use in immunotherapy against an infection by sars-cov-2 (covid-19)UNIV TUEBINGEN MEDIZINISCHE FAKULTAET·Filed 2022·Application pending·0 cites
- 2352US2022332764A1T cell epitopes of hcmv and uses of thereofUNIV EBERHARD KARLS TUEBINGEN·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Annika Nelde files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →